# FDA Inspection 1178029 - ImpactLife - August 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/impactlife/67f16ea3-791e-4961-978b-a03f8aba8fea
Source feed: FDA_Inspections

> FDA Inspection 1178029 for ImpactLife on August 22, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1178029
- Company Name: ImpactLife
- Inspection Date: 2022-08-22
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1178029 - 2022-08-22](https://www.keypedia.com/records/fda_inspections/impactlife/bbca8371-0a12-41f7-ad22-9957de809163)
- [FDA Inspection 999388 - 2017-01-18](https://www.keypedia.com/records/fda_inspections/impactlife/f1babec5-b757-4b6f-82b3-d948f7d9b4dc)
- [FDA Inspection 828387 - 2013-04-22](https://www.keypedia.com/records/fda_inspections/impactlife/f43310f8-f2bd-4abe-b457-3e95ce218ab0)
- [FDA Inspection 694961 - 2010-10-25](https://www.keypedia.com/records/fda_inspections/impactlife/305e82d7-82fd-41db-89e5-626f1dd8f6ee)

Company: https://www.keypedia.com/companies/impactlife/62565fc4-6838-494d-8458-4789aff6bb7c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d